Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis
Key Points
Higher mycophenolate mofetil levels correlate with improved transplant outcomes, especially in GVHD prophylaxis.
Notably, patients receiving post-transplant cyclophosphamide and high mycophenolate mofetil showed 20% fewer complications.
Observational analysis focused on transplant patients treated with specific immunosuppressive regimens in clinical settings.
Further studies are needed to explore optimal mycophenolate mofetil dosing for enhanced patient outcomes.
Like
Bookmark
Share
Like
Bookmark
Share
Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis | Synapse